These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 19077262)
1. TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma. Daigeler A; Brenzel C; Bulut D; Geisler A; Hilgert C; Lehnhardt M; Steinau HU; Flier A; Steinstraesser L; Klein-Hitpass L; Mittelkötter U; Uhl W; Chromik AM J Exp Clin Cancer Res; 2008 Dec; 27(1):82. PubMed ID: 19077262 [TBL] [Abstract][Full Text] [Related]
2. Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus. Daigeler A; Chromik AM; Geisler A; Bulut D; Hilgert C; Krieg A; Klein-Hitpass L; Lehnhardt M; Uhl W; Mittelkötter U Int J Oncol; 2008 Jun; 32(6):1205-20. PubMed ID: 18497982 [TBL] [Abstract][Full Text] [Related]
3. TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells. Harati K; Chromik AM; Bulut D; Goertz O; Hahn S; Hirsch T; Klein-Hitpass L; Lehnhardt M; Uhl W; Daigeler A Anticancer Res; 2012 Jul; 32(7):2967-84. PubMed ID: 22753761 [TBL] [Abstract][Full Text] [Related]
4. Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma. Karlisch C; Harati K; Chromik AM; Bulut D; Klein-Hitpass L; Goertz O; Hirsch T; Lehnhardt M; Uhl W; Daigeler A Int J Oncol; 2013 Mar; 42(3):945-56. PubMed ID: 23338823 [TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma. Daigeler A; Chromik AM; Haendschke K; Emmelmann S; Siepmann M; Hensel K; Schmitz G; Klein-Hitpass L; Steinau HU; Lehnhardt M; Hauser J Ultrasound Med Biol; 2010 Nov; 36(11):1893-906. PubMed ID: 20870344 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells. Chromik AM; Daigeler A; Hilgert C; Bulut D; Geisler A; Liu V; Otte JM; Uhl W; Mittelkötter U J Invest Surg; 2007; 20(6):339-48. PubMed ID: 18097875 [TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of cell death induction by taurolidine in different malignant cell lines. Chromik AM; Hahn SA; Daigeler A; Flier A; Bulut D; May C; Harati K; Roschinsky J; Sülberg D; Weyhe D; Mittelkötter U; Uhl W BMC Cancer; 2010 Oct; 10():595. PubMed ID: 21034493 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines. Chromik AM; Daigeler A; Bulut D; Flier A; May C; Harati K; Roschinsky J; Sülberg D; Ritter PR; Mittelkötter U; Hahn SA; Uhl W J Exp Clin Cancer Res; 2010 Mar; 29(1):21. PubMed ID: 20205945 [TBL] [Abstract][Full Text] [Related]
9. Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines. Hotz B; Erben U; Arndt M; Buhr HJ; Hotz HG Int J Colorectal Dis; 2014 Nov; 29(11):1339-48. PubMed ID: 25179425 [TBL] [Abstract][Full Text] [Related]
10. Combinatorial effect of curcumin and tumor necrosis factor-α-related apoptosis-inducing ligand (TRAIL) in induction of apoptosis via inhibition of nuclear factor kappa activity and enhancement of caspase-3 activity in chronic myeloid cells: An Iqbal B; Ghildiyal A; Singh S; Siddiqui S; Kumari P; Arshad M; Mahdi AA J Cancer Res Ther; 2018 Dec; 14(Supplement):S1193-S1200. PubMed ID: 30539870 [TBL] [Abstract][Full Text] [Related]
11. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Itashiki Y; Harada K; Ferdous T; Yoshida H Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527 [TBL] [Abstract][Full Text] [Related]
12. TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo. Wang S; Ren W; Liu J; Lahat G; Torres K; Lopez G; Lazar AJ; Hayes-Jordan A; Liu K; Bankson J; Hazle JD; Lev D Clin Cancer Res; 2010 May; 16(9):2591-604. PubMed ID: 20406839 [TBL] [Abstract][Full Text] [Related]
13. Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer. Li F; Qi J; Qin C; Fu Z; Ren W Oncol Rep; 2018 Dec; 40(6):3743-3751. PubMed ID: 30272302 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells. Harati K; Slodnik P; Chromik AM; Goertz O; Hirsch T; Kapalschinski N; Klein-Hitpass L; Kolbenschlag J; Uhl W; Lehnhardt M; Daigeler A Anticancer Res; 2015 Feb; 35(2):767-74. PubMed ID: 25667456 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer. Darnowski JW; Goulette FA; Cousens LP; Chatterjee D; Calabresi P Cancer Chemother Pharmacol; 2004 Sep; 54(3):249-58. PubMed ID: 15173956 [TBL] [Abstract][Full Text] [Related]
16. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer. Zhu K; Fang W; Chen Y; Lin S; Chen X Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445 [TBL] [Abstract][Full Text] [Related]
17. Pro‑apoptotic effects of pycnogenol on HT1080 human fibrosarcoma cells. Harati K; Slodnik P; Chromik AM; Behr B; Goertz O; Hirsch T; Kapalschinski N; Klein-Hitpass L; Kolbenschlag J; Uhl W; Lehnhardt M; Daigeler A Int J Oncol; 2015 Apr; 46(4):1629-36. PubMed ID: 25625225 [TBL] [Abstract][Full Text] [Related]
18. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells. Murtaza I; Saleem M; Adhami VM; Hafeez BB; Mukhtar H Cancer Res; 2009 Feb; 69(3):1156-65. PubMed ID: 19176377 [TBL] [Abstract][Full Text] [Related]
19. Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors. Kamat AM; Tharakan ST; Sung B; Aggarwal BB Cancer Res; 2009 Dec; 69(23):8958-66. PubMed ID: 19903839 [TBL] [Abstract][Full Text] [Related]
20. PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation. Tanaka H; Hoshikawa Y; Oh-hara T; Koike S; Naito M; Noda T; Arai H; Tsuruo T; Fujita N Mol Cancer Res; 2009 Apr; 7(4):557-69. PubMed ID: 19372584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]